While running a comparative study between lots, the customer reported (b)(6) architect havab-g assay results for four patients on the current lot 12026be00, which was used for individual patient management.The customer provided: (b)(6) initial = (b)(6); (b)(6) initial = (b)(6); (b)(6) initial = (b)(6); (b)(6) initial = (b)(6).(ranges: (b)(6)).There was no impact to patient management reported.
|
The evaluation of the customer issue included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and field data review.Trending review determined no trend for this issue for the product.Device history record review did not identify any non-conformances or deviations associated with the customers issue.The overall performance of architect havab-g reagents in the field was reviewed and found to be acceptable.Based on all available information no product deficiency was identified.
|